Nav: Home

Opioid crisis leads to rise in viable hearts and lungs for those awaiting transplants

May 16, 2018

Last year, a record number of heart transplants were performed in the U.S., but analyses of the data show a dark reason behind this good news: A sharp rise in organ donations is largely driven by the U.S. drug-abuse epidemic. A new study published in The New England Journal of Medicine by investigators from Brigham and Women's Hospital and University of Utah, examines survival outcomes for patients who have received organs from donors who died of drug intoxication. The team reports no significant difference in survival outcomes among patients who received heart and lung transplants from donors who died of drug intoxication, despite these organs being especially sensitive to restrictions in blood supply.

The study also compares donations in the U.S. and Europe. The team saw a jump in the number of organ donors in the U.S. who had died from intoxication - from 59 in the year 2000 to 1,029 in 2016. Over the same span of time, there was no significant change in the number of organ donor deaths from intoxication in Europe.

"We wanted to understand the impact of the drug abuse epidemic on the most vulnerable segments of organ transplants, which include heart and lung organs," said Mandeep R. Mehra, MD, FACC, FESC, FHFSA, FRCP, executive director of the Center for Advanced Heart Disease and medical director of the Heart & Vascular Center at BWH. "Importantly, we were curious to understand if the drug-abuse epidemic is affecting organ donations globally or if this effect is restricted to the United States. We were surprised to find that this is a U.S. issue and not at all seen in the European transplant experience."

Survival rates one year after heart or lung transplantation were similar for recipients who received organs from donors who died from drug intoxication and for those who received organs from donors who died of other causes.

"It's important to remember that while more people are receiving the gift of life, other lives are being lost," said Mehra. "Instead of scientific advancements driving an increase in the pool of available organs, this increase is driven by a crisis, and we cannot rely on this as a source indefinitely. As efforts in health policy to overcome this crisis take root, the transplant community must turn to sustainable ways to increase organ donor recovery."

Investigators at BWH and elsewhere are currently exploring ways to recover organs from current donors considered less suitable. Some of the novel sources being considered are high-risk organs from donors infected with treatable diseases such as hepatitis C or those from donors who experienced cardiac death.
-end-
Paper cited: Mehra, Mandeep et al. "The Drug-Intoxication Epidemic and Solid-Organ Transplantation" NEJM DOI: 10.1056/ NEJMc1802706

Brigham and Women's Hospital

Related Lung Transplantation Articles:

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.
Women are less likely to receive lung protective tidal volumes when being considered as a lung donor
A study presented at the CHEST Annual Meeting 2018 in San Antonio examined the adherence to lung protective ventilation and whether there were sex specific differences in mechanical ventilation strategies.
Engrafted stem cell-derived lung organoids that model human lung development
Researchers have now grown lung organoids from human embryonic stem cells (hESCs) that, after implantation in mice, can develop mature alveolar type 1 (AT1) and AT2 cells and architecture approximating that of human lungs.
Single transplantation of therapeutic macrophages improves rare lung disease in mice
Hereditary pulmonary alveolar proteinosis (herPAP) is a rare disease characterized by the slow build-up of lipo-protein material in the lungs due to the failure of highly specialized cells called macrophages, which usually eat away this material from the pulmonary air-space.
Advancing transplantation: Hepatitis C-infected organs safe for transplantation when followed by antiviral treatment
Twenty patients at Penn Medicine have been cured of the hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease, according to a study published today in Annals of Internal Medicine.
Chinese researchers report first lung stem cell transplantation clinical trial
A research team from Tongji University in China have made a breakthrough in human lung regeneration technology.
The Journal of Heart and Lung Transplantation: 50 years of heart transplantation progress
This month marks the 50th anniversary of the world's first human heart transplant performed at Groote Schuur Hospital in Cape Town by South African surgeon, Christiaan Barnard.
Hepatocellular carcinoma: Resection vs. transplantation
Liver transplantation is the gold standard for treating early hepatocellular cancers.
New lung 'organoids' in a dish mimic features of full-size lung
New lung 'organoids' -- tiny 3-D structures that mimic features of a full-sized lung -- have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC).
Lung ultrasound can help doctors see other diseases that mask as lethal clots in lung
Lung ultrasound can show alternative diagnoses and should be considered when evaluating patients with suspected pulmonary embolism.
More Lung Transplantation News and Lung Transplantation Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.